Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall.

Egan C, Laurent C, Alejo JC, Pileri S, Campo E, Swerdlow SH, Piris M, Chan WC, Warnke R, Gascoyne RD, Xi L, Raffeld M, Pittaluga S, Jaffe ES.

Am J Surg Pathol. 2019 Nov 22. doi: 10.1097/PAS.0000000000001414. [Epub ahead of print]

PMID:
31764221
2.

Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma.

Fuster C, Martín-Garcia D, Balagué O, Navarro A, Nadeu F, Costa D, Prieto M, Salaverria I, Espinet B, Rivas-Delgado A, Terol MJ, Giné E, Forcada P, Ashton-Key M, Puente XS, Swerdlow SH, Beà S, Campo E.

Haematologica. 2019 Nov 21. pii: haematol.2019.237073. doi: 10.3324/haematol.2019.237073. [Epub ahead of print] No abstract available.

3.

As the world turns, evolving lymphoma classifications - past, present and future.

Swerdlow SH, Cook JR.

Hum Pathol. 2019 Sep 4. pii: S0046-8177(19)30159-5. doi: 10.1016/j.humpath.2019.08.019. [Epub ahead of print]

PMID:
31493426
4.

Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases.

Carlsen ED, Swerdlow SH, Cook JR, Gibson SE.

Am J Surg Pathol. 2019 Oct;43(10):1403-1412. doi: 10.1097/PAS.0000000000001363.

PMID:
31464711
5.

Harmonization of Training, Training Requirements, Board Certification, and Practice of Hematopathology.

Swerdlow SH, Monaghan SA, Douglas AR, Johnson K, Johnson RL.

Am J Clin Pathol. 2019 Oct 7;152(5):625-637. doi: 10.1093/ajcp/aqz084.

PMID:
31338515
6.

Molecular and Cytogenetic Education in Hematopathology Fellowship.

Soma LA, Kovach AE, Siddon AJ, Beck R, Gibson SE, Swerdlow SH, Kim AS, Wu D, Jones D, Cook JR, Prakash S, Rosado F, Crane G, Bradley K, Weinberg OK, Sargent RL.

Am J Clin Pathol. 2019 Sep 9;152(4):438-445. doi: 10.1093/ajcp/aqz048.

PMID:
31141139
7.

Low-level BCR-ABL1 transcripts in individuals without overt hematologic malignancy.

Leeman-Neill RJ, Swerdlow SH, Burnes CL, Melan MA, Nikiforova MN, Surti U, Aggarwal N.

Leuk Res. 2019 Jun;81:98-101. doi: 10.1016/j.leukres.2019.04.009. Epub 2019 Apr 22. No abstract available.

PMID:
31047698
8.

Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses.

Cascione L, Rinaldi A, Bruscaggin A, Tarantelli C, Arribas AJ, Kwee I, Pecciarini L, Mensah AA, Spina V, Chung EYL, di Bergamo LT, Dirnhofer S, Tzankov A, Miranda RN, Young KH, Traverse-Glehen A, Gaidano G, Swerdlow SH, Gascoyne R, Rabadan R, Ponzoni M, Bhagat G, Rossi D, Zucca E, Bertoni F.

Haematologica. 2019 Dec;104(12):e558-e561. doi: 10.3324/haematol.2018.214957. Epub 2019 Apr 24. No abstract available.

9.

More on Blastic Plasmacytoid Dendritic-Cell Neoplasms.

Agha ME, Monaghan SA, Swerdlow SH.

N Engl J Med. 2019 Feb 14;380(7):696-697. doi: 10.1056/NEJMc1814963. No abstract available.

PMID:
30763185
10.

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES.

Blood. 2019 Apr 18;133(16):1703-1714. doi: 10.1182/blood-2018-11-881268. Epub 2019 Jan 11. Review. Erratum in: Blood. 2019 Sep 26;134(13):1112.

PMID:
30635287
11.

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma.

Martín-Garcia D, Navarro A, Valdés-Mas R, Clot G, Gutiérrez-Abril J, Prieto M, Ribera-Cortada I, Woroniecka R, Rymkiewicz G, Bens S, de Leval L, Rosenwald A, Ferry JA, Hsi ED, Fu K, Delabie J, Weisenburger D, de Jong D, Climent F, O'Connor SJ, Swerdlow SH, Torrents D, Beltran S, Espinet B, González-Farré B, Veloza L, Costa D, Matutes E, Siebert R, Ott G, Quintanilla-Martinez L, Jaffe ES, López-Otín C, Salaverria I, Puente XS, Campo E, Beà S.

Blood. 2019 Feb 28;133(9):940-951. doi: 10.1182/blood-2018-07-862151. Epub 2018 Dec 11.

PMID:
30538135
12.

Diagnostic Utility of Isolated Tube C Positivity in T-Cell Receptor β Testing Using BIOMED-2 Primers.

Qayyum S, Bullock GC, Swerdlow SH, Brower R, Nikiforova M, Aggarwal N.

Am J Clin Pathol. 2019 Mar 1;151(4):386-394. doi: 10.1093/ajcp/aqy157.

PMID:
30534953
13.

Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell Neoplasm.

Agha ME, Monaghan SA, Swerdlow SH.

N Engl J Med. 2018 Oct 11;379(15):1479-1481. doi: 10.1056/NEJMc1808354. No abstract available.

PMID:
30304659
14.

Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease.

Chen BJ, Ruminy P, Roth CG, Bisig B, Mankel B, Steinhilber J, Bohers E, Jardin F, Fend F, Swerdlow SH, Copie-Bergman C, de Leval L, Quintanilla-Martinez L.

Am J Surg Pathol. 2019 Jan;43(1):110-120. doi: 10.1097/PAS.0000000000001154.

PMID:
30211726
15.

Circular DNA tumor viruses make circular RNAs.

Toptan T, Abere B, Nalesnik MA, Swerdlow SH, Ranganathan S, Lee N, Shair KH, Moore PS, Chang Y.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8737-E8745. doi: 10.1073/pnas.1811728115. Epub 2018 Aug 27.

16.

Langerin staining identifies most littoral cell angiomas but not most other splenic angiomatous lesions.

Selove W, Picarsic J, Swerdlow SH.

Hum Pathol. 2019 Jan;83:43-49. doi: 10.1016/j.humpath.2018.08.012. Epub 2018 Aug 18.

PMID:
30130631
17.

Location matters in early stage nodal diffuse large B-cell lymphoma.

Lontos K, Tsagianni A, Yuan JM, Normolle DP, Boyiadzis M, Hou JZ, Swerdlow SH, Dorritie KA.

Leuk Lymphoma. 2019 Jan;60(1):250-253. doi: 10.1080/10428194.2018.1471600. Epub 2018 Jun 22. No abstract available.

18.

Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.

Moore EM, Swerdlow SH, Gibson SE.

Am J Surg Pathol. 2018 Mar;42(3):342-350. doi: 10.1097/PAS.0000000000001015.

PMID:
29309299
19.
20.

Further Exploration of the Complexities of Large B-Cell Lymphomas With MYC Abnormalities and the Importance of a Blastoid Morphology.

Moore EM, Aggarwal N, Surti U, Swerdlow SH.

Am J Surg Pathol. 2017 Sep;41(9):1155-1166. doi: 10.1097/PAS.0000000000000818.

PMID:
28614202
21.

Cutaneous marginal zone lymphomas.

Swerdlow SH.

Semin Diagn Pathol. 2017 Jan;34(1):76-84. doi: 10.1053/j.semdp.2016.11.007. Epub 2016 Nov 29. Review.

PMID:
27986434
22.

CD56- extranodal natural killer (NK)/T-cell lymphoma, nasal type presenting as skin ulcers in a white man.

Vainder C, Ho J, Swerdlow SH, Akilov OE.

JAAD Case Rep. 2016 Oct 8;2(5):390-396. eCollection 2016 Sep. No abstract available.

23.

Does Taking the Fellowship In-Service Hematopathology Examination and Performance Relate to Success on the American Board of Pathology Hematology Examination?

Monaghan SA, Felgar RE, Kelly MA, Ali AM, Anastasi J, Bellara AP, Rinder HM, Sargent RL, Wagner J, Swerdlow SH, Johnson RL.

Am J Clin Pathol. 2016 Jul;146(1):107-12. doi: 10.1093/ajcp/aqw085. Epub 2016 Jun 29.

PMID:
27357289
24.

CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.

Gooden CE, Jones P, Bates R, Shallenberger WM, Surti U, Swerdlow SH, Roth CG.

Cytometry B Clin Cytom. 2018 Jan;94(1):129-135. doi: 10.1002/cyto.b.21384. Epub 2016 Jun 27.

25.

Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.

Gibson SE, Picarsic J, Swerdlow SH, Pantanowitz L.

Cancer Cytopathol. 2016 Jun;124(6):425-35. doi: 10.1002/cncy.21694. Epub 2016 Mar 17.

26.

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES.

Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15. Review.

27.

In this issue: small B cell lymphomas, more than just a size.

Quintanilla-Martinez L, Swerdlow SH, Campo E.

Virchows Arch. 2016 Feb;468(2):125-6. doi: 10.1007/s00428-016-1912-2. No abstract available.

PMID:
26886760
28.

Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.

Aggarwal N, Swerdlow SH, TenEyck SP, Boyiadzis M, Felgar RE.

Cytometry B Clin Cytom. 2016 Jul;90(4):349-57. doi: 10.1002/cyto.b.21349. Epub 2016 Feb 3.

29.

Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene.

Gibson SE, Leeman-Neill RJ, Jain S, Piao W, Cieply KM, Swerdlow SH.

Br J Haematol. 2016 Oct;175(1):173-5. doi: 10.1111/bjh.13844. Epub 2015 Nov 16. No abstract available.

PMID:
26568397
30.

The heterogeneity of follicular lymphomas: from early development to transformation.

Xerri L, Dirnhofer S, Quintanilla-Martinez L, Sander B, Chan JK, Campo E, Swerdlow SH, Ott G.

Virchows Arch. 2016 Feb;468(2):127-39. doi: 10.1007/s00428-015-1864-y. Epub 2015 Oct 19. Review.

PMID:
26481245
31.

The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.

Swerdlow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JK, Sander B, Ott G, Xerri L, Quintanilla-Martinez L, Campo E.

Virchows Arch. 2016 Mar;468(3):259-75. doi: 10.1007/s00428-015-1858-9. Epub 2015 Oct 10. Review.

32.

Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.

Quintanilla-Martinez L, Sander B, Chan JK, Xerri L, Ott G, Campo E, Swerdlow SH.

Virchows Arch. 2016 Feb;468(2):141-57. doi: 10.1007/s00428-015-1855-z. Epub 2015 Sep 28. Review.

PMID:
26416032
33.

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.

King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, Sattler CA, Ketterling RP, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Gibson SE, Ondrejka SL, Nicolae A, Macon WR, Dasari S, Parrilla Castellar E, Feldman AL.

Am J Surg Pathol. 2016 Jan;40(1):36-43. doi: 10.1097/PAS.0000000000000500.

34.

Expression of S100 Protein in CD4-positive T-cell Lymphomas Is Often Associated With T-cell Prolymphocytic Leukemia.

Aggarwal N, Pongpruttipan T, Patel S, Bayerl MG, Alkan S, Nathwani B, Surti U, Kitahara S, Chinthammitr Y, Swerdlow SH.

Am J Surg Pathol. 2015 Dec;39(12):1679-87. doi: 10.1097/PAS.0000000000000496.

PMID:
26379148
35.

A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease.

Ohno K, Sato Y, Ohshima K, Takata K, Miyata-Takata T, Takeuchi M, Gion Y, Tachibana T, Orita Y, Ito T, Swerdlow SH, Yoshino T.

Sci Rep. 2015 Aug 27;5:13539. doi: 10.1038/srep13539.

36.

Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?

Peterson JF, Aggarwal N, Smith CA, Gollin SM, Surti U, Rajkovic A, Swerdlow SH, Yatsenko SA.

Oncotarget. 2015 Aug 7;6(22):18845-62.

37.

Mantle cell lymphoma--a spectrum from indolent to aggressive disease.

Sander B, Quintanilla-Martinez L, Ott G, Xerri L, Kuzu I, Chan JK, Swerdlow SH, Campo E.

Virchows Arch. 2016 Mar;468(3):245-57. doi: 10.1007/s00428-015-1840-6. Epub 2015 Aug 23. Review.

PMID:
26298543
38.

Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.

Turakhia S, Lanigan C, Hamadeh F, Swerdlow SH, Tubbs RR, Cook JR.

Am J Clin Pathol. 2015 Jul;144(1):87-93. doi: 10.1309/AJCP5WVXJ2KTLODO.

PMID:
26071465
39.

Evaluating breast lymphoplasmacytic infiltrates: a multiparameter immunohistochemical study, including assessment of IgG4.

Berg AN, Soma L, Clark BZ, Swerdlow SH, Roth CG.

Hum Pathol. 2015 Aug;46(8):1162-70. doi: 10.1016/j.humpath.2015.04.006. Epub 2015 Apr 28.

PMID:
26026200
40.

Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle?

Tandon B, Swerdlow SH, Hasserjian RP, Surti U, Gibson SE.

Leuk Lymphoma. 2015;56(12):3378-86. doi: 10.3109/10428194.2015.1037759. Epub 2015 May 26.

PMID:
25860247
41.

Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.

Swerdlow SH.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):90-9. doi: 10.1182/asheducation-2014.1.90. Epub 2014 Nov 18. Review.

PMID:
25696840
42.

Robert Deaver Collins (1928-2013): a life dedicated to teaching, investigation, and concern for human beings and our earth.

Kinney MC, Cousar JB, Swerdlow SH.

Am J Surg Pathol. 2014 Dec;38(12):1726-9. doi: 10.1097/PAS.0000000000000331. No abstract available.

PMID:
25321331
43.

Plasma cell (Zoon) balanitis: another inflammatory disorder that can be rich in IgG4+ plasma cells.

Aggarwal N, Parwani AV, Ho J, Cook JR, Swerdlow SH.

Am J Surg Pathol. 2014 Oct;38(10):1437-43. doi: 10.1097/PAS.0000000000000269.

PMID:
25216321
44.

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Hamadeh F, MacNamara SP, Aguilera NS, Swerdlow SH, Cook JR.

Mod Pathol. 2015 Apr;28(4):564-74. doi: 10.1038/modpathol.2014.120. Epub 2014 Sep 12.

45.

Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies.

Swerdlow SH, Jaffe ES, Brousset P, Chan JK, de Leval L, Gaulard P, Harris NL, Pileri S, Weiss LM; International Lymphoma Study Group.

Am J Surg Pathol. 2014 Oct;38(10):e60-71. doi: 10.1097/PAS.0000000000000295. Review.

46.

Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates.

Cogbill CH, Swerdlow SH, Gibson SE.

Am J Clin Pathol. 2014 Jul;142(1):88-98. doi: 10.1309/AJCPWF77VOGNOVZU.

PMID:
24926091
47.

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL.

Blood. 2014 Aug 28;124(9):1473-80. doi: 10.1182/blood-2014-04-571091. Epub 2014 Jun 3.

48.

Gamma heavy chain disease lacks the MYD88 L265p mutation associated with lymphoplasmacytic lymphoma.

Hamadeh F, MacNamara S, Bacon CM, Sohani AR, Swerdlow SH, Cook JR.

Haematologica. 2014 Sep;99(9):e154-5. doi: 10.3324/haematol.2014.108688. Epub 2014 May 23. No abstract available.

49.

Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease.

Takeuchi M, Sato Y, Yasui H, Ozawa H, Ohno K, Takata K, Gion Y, Orita Y, Tachibana T, Itoh T, Asano N, Nakamura S, Swerdlow SH, Yoshino T.

Am J Surg Pathol. 2014 Jul;38(7):946-55. doi: 10.1097/PAS.0000000000000206.

PMID:
24705309
50.

Whole-genome single nucleotide polymorphism array analysis is complementary to classical cytogenetic analysis in the evaluation of lymphoid proliferations.

Gibson SE, Luo J, Sathanoori M, Liao J, Surti U, Swerdlow SH.

Am J Clin Pathol. 2014 Feb;141(2):247-55. doi: 10.1309/AJCPRHGHT28DUWLA.

PMID:
24436273

Supplemental Content

Loading ...
Support Center